Ravinder Wali to Humans
This is a "connection" page, showing publications Ravinder Wali has written about Humans.
Connection Strength
0.210
-
Wali RK, Lee AH, Kam JC, Jonsson J, Thatcher A, Poretz D, Ambardar S, Piper J, Lynch C, Kulkarni S, Cochran J, Djurkovic S. Acute Neurological Illness in a Kidney Transplant Recipient Following Infection With Enterovirus-D68: An Emerging Infection? Am J Transplant. 2015 Dec; 15(12):3224-8.
Score: 0.018
-
Karam S, Wali RK. Current State of Immunosuppression: Past, Present, and Future. Crit Rev Eukaryot Gene Expr. 2015; 25(2):113-34.
Score: 0.017
-
Wali RK, Iyengar M, Beck GJ, Chartyan DM, Chonchol M, Lukas MA, Cooper C, Himmelfarb J, Weir MR, Berl T, Henrich WL, Cheung AK. Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials. Circ Heart Fail. 2011 Jan; 4(1):18-26.
Score: 0.013
-
Wali RK. Aspirin and the prevention of cardiovascular disease in chronic kidney disease: time to move forward? J Am Coll Cardiol. 2010 Sep 14; 56(12):966-8.
Score: 0.013
-
Weir MR, Wali RK. Optimizing immunosuppression with sirolimus in the first year posttransplantation: experience in the United States. Transplant Proc. 2009 Jul-Aug; 41(6 Suppl):S13-7.
Score: 0.012
-
Weir MR, Wali RK. Minimizing the risk of chronic allograft nephropathy. Transplantation. 2009 Apr 27; 87(8 Suppl):S14-8.
Score: 0.012
-
Wali RK, Weir MR. Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function? Curr Opin Organ Transplant. 2008 Dec; 13(6):614-21.
Score: 0.011
-
Hitti WA, Papadimitriou JC, Bartlett S, Wali RK. Spontaneous cutaneous ulcers in a patient with a moderate degree of chronic kidney disease: a different spectrum of calciphylaxis. Scand J Urol Nephrol. 2008; 42(2):181-3.
Score: 0.011
-
Wali RK, Mohanlal V, Ramos E, Blahut S, Drachenberg C, Papadimitriou J, Dinits M, Joshi A, Philosophe B, Foster C, Cangro C, Nogueira J, Cooper M, Bartlett ST, Weir MR. Early withdrawal of calcineurin inhibitors and rescue immunosuppression with sirolimus-based therapy in renal transplant recipients with moderate to severe renal dysfunction. Am J Transplant. 2007 Jun; 7(6):1572-83.
Score: 0.010
-
Wali RK, Henrich WL. Chronic kidney disease: a risk factor for cardiovascular disease. Cardiol Clin. 2005 Aug; 23(3):343-62.
Score: 0.009
-
Wali RK, Wang GS, Gottlieb SS, Bellumkonda L, Hansalia R, Ramos E, Drachenberg C, Papadimitriou J, Brisco MA, Blahut S, Fink JC, Fisher ML, Bartlett ST, Weir MR. Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease. J Am Coll Cardiol. 2005 Apr 05; 45(7):1051-60.
Score: 0.009
-
Wali RK, Drachenberg C, Hirsch HH, Papadimitriou J, Nahar A, Mohanlal V, Brisco MA, Bartlett ST, Weir MR, Ramos E. BK virus-associated nephropathy in renal allograft recipients: rescue therapy by sirolimus-based immunosuppression. Transplantation. 2004 Oct 15; 78(7):1069-73.
Score: 0.009
-
Ramos E, Vincenti F, Lu WX, Shapiro R, Trofe J, Stratta RJ, Jonsson J, Randhawa PS, Drachenberg CB, Papadimitriou JC, Weir MR, Wali RK. Retransplantation in patients with graft loss caused by polyoma virus nephropathy. Transplantation. 2004 Jan 15; 77(1):131-3.
Score: 0.008
-
Wali RK, Henrich WL. Recent developments in toxic nephropathy. Curr Opin Nephrol Hypertens. 2002 Mar; 11(2):155-63.
Score: 0.007
-
Wali RK, Weir MR. Hypertensive cardiovascular disease in African Americans. Curr Hypertens Rep. 1999 Dec; 1(6):521-8.
Score: 0.006
-
Wali RK, Drachenberg CI, Papadimitriou JC, Keay S, Ramos E. HIV-1-associated nephropathy and response to highly-active antiretroviral therapy. Lancet. 1998 Sep 05; 352(9130):783-4.
Score: 0.006
-
Siskind E, Amodu L, Liu C, Akerman M, Stodghill J, Wali R, Piper J, Jonsson J, Molmenti E, Ortiz J. A comparison of portal venous versus systemic venous drainage in pancreas transplantation. HPB (Oxford). 2019 02; 21(2):195-203.
Score: 0.006
-
Ramos E, Drachenberg CB, Wali R, Hirsch HH. The decade of polyomavirus BK-associated nephropathy: state of affairs. Transplantation. 2009 Mar 15; 87(5):621-30.
Score: 0.003
-
Hitti WA, Wali RK, Weinman EJ, Weiman EJ, Drachenberg C, Briglia A. Cholesterol embolization syndrome induced by thrombolytic therapy. Am J Cardiovasc Drugs. 2008; 8(1):27-34.
Score: 0.003
-
Drachenberg CB, Hirsch HH, Papadimitriou JC, Gosert R, Wali RK, Munivenkatappa R, Nogueira J, Cangro CB, Haririan A, Mendley S, Ramos E. Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation. Transplantation. 2007 Aug 15; 84(3):323-30.
Score: 0.003
-
Chan-Tack KM, Ahuja N, Weinman EJ, Wali RK, Uche A, Greisman LA, Drachenberg C, Hawkins PN, Redfield RR. Acute renal failure and nephrotic range proteinuria due to amyloidosis in an HIV-infected patient. Am J Med Sci. 2006 Dec; 332(6):364-7.
Score: 0.002
-
Drachenberg CB, Papadimitriou JC, Mann D, Hirsch HH, Wali R, Ramos E. Negative impact of human leukocyte antigen matching in the outcome of polyomavirus nephropathy. Transplantation. 2005 Jul 27; 80(2):276-8.
Score: 0.002
-
Drachenberg CB, Papadimitriou JC, Hirsch HH, Wali R, Crowder C, Nogueira J, Cangro CB, Mendley S, Mian A, Ramos E. Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral load. Am J Transplant. 2004 Dec; 4(12):2082-92.
Score: 0.002
-
Drachenberg C, Hirsch HH, Papadimitriou JC, Mozafari P, Wali R, McKinney JD, Nogueira J, Cangro CB, Mendley S, Klassen DK, Ramos E. Cost efficiency in the prospective diagnosis and follow-up of polyomavirus allograft nephropathy. Transplant Proc. 2004 Dec; 36(10):3028-31.
Score: 0.002
-
Drachenberg CB, Papadimitriou JC, Wali R, Nogueira J, Mendley S, Hirsch HH, Cangro CB, Klassen DK, Weir MR, Bartlett ST, Ramos E. Improved outcome of polyoma virus allograft nephropathy with early biopsy. Transplant Proc. 2004 Apr; 36(3):758-9.
Score: 0.002
-
Drachenberg CB, Papadimitriou JC, Wali R, Cubitt CL, Ramos E. BK polyoma virus allograft nephropathy: ultrastructural features from viral cell entry to lysis. Am J Transplant. 2003 Nov; 3(11):1383-92.
Score: 0.002
-
Papadimitriou JC, Drachenberg CB, Klassen DK, Gaber L, Racusen LC, Voska L, Cangro CB, Ramos E, Wali R, Weir MR, Bartlett ST. Histological grading of chronic pancreas allograft rejection/graft sclerosis. Am J Transplant. 2003 May; 3(5):599-605.
Score: 0.002
-
Ramos E, Drachenberg CB, Papadimitriou JC, Hamze O, Fink JC, Klassen DK, Drachenberg RC, Wiland A, Wali R, Cangro CB, Schweitzer E, Bartlett ST, Weir MR. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol. 2002 Aug; 13(8):2145-51.
Score: 0.002
-
Onuigbo M, Haririan A, Ramos E, Klassen D, Wali R, Drachenberg C. Cytomegalovirus-induced glomerular vasculopathy in renal allografts: a report of two cases. Am J Transplant. 2002 Aug; 2(7):684-8.
Score: 0.002
-
Weinman EJ, Lakkis J, Akom M, Wali RK, Drachenberg CB, Coleman RA, Wade JB. Expression of NHERF-1, NHERF-2, PDGFR-alpha, and PDGFR-beta in normal human kidneys and in renal transplant rejection. Pathobiology. 2002-2003; 70(6):314-23.
Score: 0.002
-
Ramos E, Drachenberg CB, Portocarrero M, Wali R, Klassen DK, Fink JC, Farney A, Hirsch H, Papadimitriou JC, Cangro CB, Weir MR, Bartlett ST. BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program. Clin Transpl. 2002; 143-53.
Score: 0.002
-
Drachenberg RC, Drachenberg CB, Papadimitriou JC, Ramos E, Fink JC, Wali R, Weir MR, Cangro CB, Klassen DK, Khaled A, Cunningham R, Bartlett ST. Morphological spectrum of polyoma virus disease in renal allografts: diagnostic accuracy of urine cytology. Am J Transplant. 2001 Nov; 1(4):373-81.
Score: 0.002
-
Joseph A, Wali RK, Weinman EJ. Renal amyloidosis in AIDS. Ann Intern Med. 2000 Jul 04; 133(1):75.
Score: 0.002